KYNTRA BIO, INC. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
KYNTRA BIO filed its quarterly report (10-Q) for the period ending June 30, 2026, on August 13, 2026. The document contains 63 pages of financial and operational disclosures in iXBRL format. No specific financial results, material transactions, counterparties, dollar amounts, percentages, share counts, or business developments are extractable from the filing header metadata provided.
Why this rating
Routine quarterly filing submission. No material transaction, financing, guidance change, or business event disclosed in accessible header. Standard SEC compliance filing.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.